Karen E. Knudsen
Affiliations: | University of Cincinnati, Cincinnati, OH |
Area:
Cell Biology, OncologyGoogle:
"Karen Knudsen"Children
Sign in to add traineeYelena B. Wetherill | grad student | 2005 | University of Cincinnati |
Craig J. Burd | grad student | 2006 | University of Cincinnati |
Clay E. Comstock | post-doc | 2003-2007 | (Chemistry Tree) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Galvan GC, Friedrich NA, Das S, et al. (2023) 27-hydroxycholesterol and DNA damage repair: implication in prostate cancer. Frontiers in Oncology. 13: 1251297 |
Zhao JL, Antonarakis ES, Cheng HH, et al. (2023) Phase 1b study of enzalutamide plus CC-115, a dual mTORC1/2 and DNA-PK inhibitor, in men with metastatic castration-resistant prostate cancer (mCRPC). British Journal of Cancer |
Santasusagna S, Zhu S, Jawalagatti V, et al. (2023) Master transcription factor reprograming unleashes selective translation promoting castration resistance and immune evasion in lethal prostate cancer. Cancer Discovery |
Slovin SF, Knudsen K, Halabi S, et al. (2023) Randomized Phase II Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in the Treatment of Metastatic Castration-Resistant Prostate Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2202639 |
Gordon N, Gallagher PT, Neupane NP, et al. (2023) PARP inhibition and pharmacological ascorbate demonstrate synergy in castration-resistant prostate cancer. Biorxiv : the Preprint Server For Biology |
Quinn Z, Leiby B, Sonpavde G, et al. (2022) Phase I Study of Niraparib in Combination with Radium-223 for the Treatment of Metastatic Castrate Resistant Prostate Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
Mandigo AC, Shafi AA, McCann JJ, et al. (2021) Novel oncogenic transcription factor cooperation in RB-deficient cancer. Cancer Research |
Mandigo AC, Tomlins SA, Kelly WK, et al. (2021) Relevance of pRB Loss in Human Malignancies. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
Schiewer MJ, Knudsen KE. (2021) Basic Science and Molecular Genetics of Prostate Cancer Aggressiveness. The Urologic Clinics of North America. 48: 339-347 |
Nakken S, Lilleby W, Switlyk MD, et al. (2021) The Quandary of DNA-Based Treatment Assessment in De Novo Metastatic Prostate Cancer in the Era of Precision Oncology. Journal of Personalized Medicine. 11 |